Clinical trial
Fingolimod in Preventing Paclitaxel-Associated Neuropathy in Patients With Breast Cancer
NCT03941743
Study timeline
Study start (actual)2019-12-12Date precision: day
Registry last updated2023-07-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Carcinomaunresolved
Interventions
FingolimodDRUG · verified · RxNorm: fingolimod
Fingolimod HydrochlorideDRUG · verified · RxNorm: fingolimod hydrochloride
Sponsors & collaborators
Mayo Cliniclead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03941743 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.